Organization
Baylor College of Medicine, Houston, TX
3 abstracts
Abstract
A stepped wedge trial of a healthcare provider–focused intervention to increase human papillomavirus (HPV) vaccine initiation among survivors of childhood cancer.Org: Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, Emory University, Atlanta, GA, USA, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, Emory University and Children's Healthcare of Atlanta, Atlanta, GA,
Abstract
RNA-Seq based gene expression profiling of baseline and on-treatment breast tumors to predict response to HER2-directed therapy, without chemotherapy (TBCRC026).Org: Cancer Research @UCC, Cork, Ireland, Lineberger Comprehensive Center, Chapel Hill, NC, University of California, San Francisco, CA, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD,
Abstract
A phase 1 first-in-human clinical trial of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, in advanced solid tumors.Org: Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, University of Texas Southwestern Medical Center, Dallas, TX, Stanford Cancer Center GI Surgical Oncology, Stanford, CA, Cedars-Sinai Cancer Institute, Los Angeles, CA, Cedars-Sinai Medical Center, Los Angeles, CA,